PUBLISHER: SkyQuest | PRODUCT CODE: 1481435
PUBLISHER: SkyQuest | PRODUCT CODE: 1481435
Global Vascular Closure Device Market size was valued at USD 1.59 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.80 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2024-2031).
The field of minimally invasive surgery is leading the way in continuous advancements in this regard. Angiograms are a commonly used diagnostic tool that are essential to the practice of medicine in specialties such as interventional radiology, vascular surgery, and cardiology. The rising incidence of cardiovascular illnesses combined with an increase in the number of cardiovascular patients is expected to drive the sector ahead. A significant consequence of this pattern is the increased need for vascular closure devices, which in turn leads to an increase in vascular catheterization procedures. Angiographic procedures have become increasingly common due to the rise in valvular disorders, myocardial infarction, and congenital heart ailments. These treatments, which are well-known for their capacity to minimize bleeding and hasten healing, frequently involve manual compression at the point of access. Different vascular closure devices are available, even if manual compression is still preferred.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Closure Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vascular Closure Device Market Segmental Analysis
Global Vascular Closure Device Market is segmented on the basis of Access, Product Type, End-use and region. By Product Type, the market is segmented into Active Approximators and Passive Approximators. By Access, the market is segmented into Femoral and Radial. By End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Vascular Closure Device Market
One of the primary drivers propelling the growth of the global vascular closure device market is the increasing prevalence of cardiovascular diseases worldwide. As the incidence of conditions such as coronary artery disease and peripheral artery disease rises, there is a greater demand for minimally invasive procedures to treat these ailments. Vascular closure devices offer a less invasive alternative to traditional surgical methods for closing puncture sites, leading to quicker patient recovery times and reduced hospital stays.
Restraints in the Global Vascular Closure Device Market
Despite advancements in technology, the global vascular closure device market faces a significant challenge in terms of the high cost associated with these devices. The expense of these devices may limit their adoption, particularly in regions with constrained healthcare budgets or in facilities serving low-income populations. This financial barrier could impede the widespread use of vascular closure devices, hindering patient access to potentially life-saving procedures and treatments.
Market Trends of the Global Vascular Closure Device Market
A notable trend in the global vascular closure device market is the growing preference for next-generation closure devices that offer improved efficacy and safety profiles. Manufacturers are investing in research and development to enhance the design and functionality of these devices, incorporating features such as bioresorbable materials and enhanced hemostatic properties. Additionally, there is a shift towards devices that facilitate easier deployment and removal, minimizing procedural complexities and improving patient outcomes. This trend reflects the ongoing efforts to advance the field of vascular closure technology and address the evolving needs of clinicians and patients alike.